Ethic Inc. Vertex Pharmaceuticals Inc Transaction History

Ethic Inc.

$5.89 Billion
Q3 2025

A detailed history of Ethic Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ethic Inc. holds 13,971 shares of VRTX stock, worth $6.06 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,971

Previous 11,495 21.54%

Holding current value

$6.06 Million

Previous $5.12 Million 6.92%

% of portfolio

0.09%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 17, 2025	BUY	$366.54 - $479.53 $907,553 - $1.19 Million	2,476 Added 21.54%	13,971 $5.47 Million
Q2 2025 Jul 30, 2025	BUY	$421.16 - $509.5 $24,427 - $29,551	58 Added 0.51%	11,495 $5.12 Million
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $4.65 Million - $5.94 Million	-11,553 Reduced 50.25%	11,437 $5.54 Million
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $1.27 Million - $1.65 Million	3,197 Added 16.15%	22,990 $9.26 Million
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $629,740 - $692,412	-1,369 Reduced 6.47%	19,793 $9.21 Million

Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $537,756 - $664,690	1,369 Added 6.92%	21,162 $9.92 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $879,387 - $962,194	2,157 Added 12.23%	19,793 $8.27 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $387,933 - $464,479	1,131 Added 6.85%	17,636 $7.18 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $598,240 - $641,191	1,769 Added 12.0%	16,505 $5.74 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $447,105 - $500,416	1,422 Added 10.68%	14,736 $5.19 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $1.31 Million - $1.49 Million	4,611 Added 52.98%	13,314 $4.19 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $392,062 - $441,070	1,372 Added 18.72%	8,703 $2.51 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $363,098 - $405,132	1,326 Added 22.08%	7,331 $2.12 Million
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $859,013 - $1.07 Million	3,656 Added 155.64%	6,005 $1.69 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $34,762 - $40,972	157 Added 7.16%	2,349 $613,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $335,256 - $423,214	-1,894 Reduced 46.35%	2,192 $481,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $22,492 - $25,170	-124 Reduced 2.95%	4,086 $741,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $140,430 - $165,603	749 Added 21.64%	4,210 $849,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $199,981 - $233,105	966 Added 38.72%	3,461 $744,000
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $21,529 - $28,713	-104 Reduced 4.0%	2,495 $590,000
Q3 2020 Oct 27, 2020	BUY	$255.65 - $303.1 $59,055 - $70,016	231 Added 9.76%	2,599 $707,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $320,181 - $420,036	1,420 Added 149.79%	2,368 $687,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $189,381 - $234,923	948 New	948 $226,000

Others Institutions Holding VRTX

# of Institutions

1,787

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account